RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates

by Bettina Huber, Joshua Weiyuan Wang, Richard B. S. Roden, Reinhard Kirnbauer
Published 2021-03-01

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.

by Bettina Huber, Christina Schellenbacher, Christoph Jindra, Dieter Fink, Saeed Shafti-Keramat, Reinhard Kirnbauer
Published 2015-01-01

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).

by Bettina Huber, Christina Schellenbacher, Saeed Shafti-Keramat, Christoph Jindra, Neil Christensen, Reinhard Kirnbauer
Published 2017-01-01

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

by Kihyuck Kwak, Rosie Jiang, Joshua W Wang, Subhashini Jagu, Reinhard Kirnbauer, Richard B S Roden
Published 2014-01-01

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

by Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster, Sabine Brandt, Reinhard Kirnbauer
Published 2015-01-01

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

by Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster, Sabine Brandt, Reinhard Kirnbauer
Published 2015-01-01

High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand

by Sonja Dorfer, Stefanie Kancz, Peter Birner, Katharina Strasser, Reinhard Kirnbauer, Peter Petzelbauer, Sonja Radakovic, Lucie Harpain, Hubert Pehamberger, Florian Thalhammer, Alessandra Handisurya
Published 2019-01-01